Centiva Capital LP Invests $535,000 in American Healthcare REIT, Inc. (NYSE:AHR)

Centiva Capital LP bought a new stake in American Healthcare REIT, Inc. (NYSE:AHR) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 20,482 shares of the company’s stock, valued at approximately $535,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of AHR. Kozak & Associates Inc. acquired a new stake in American Healthcare REIT during the 3rd quarter valued at approximately $28,000. Tidemark LLC acquired a new position in American Healthcare REIT during the third quarter valued at $44,000. Kessler Investment Group LLC purchased a new stake in American Healthcare REIT in the third quarter valued at $48,000. KBC Group NV acquired a new stake in American Healthcare REIT during the 3rd quarter worth about $51,000. Finally, Kiely Wealth Advisory Group Inc. acquired a new stake in American Healthcare REIT during the 2nd quarter worth about $30,000. Institutional investors and hedge funds own 16.68% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on AHR. Royal Bank of Canada upped their target price on American Healthcare REIT from $28.00 to $30.00 and gave the stock an “outperform” rating in a research note on Monday, November 18th. Morgan Stanley upped their price objective on American Healthcare REIT from $17.00 to $22.00 and gave the stock an “overweight” rating in a research report on Thursday, August 22nd. Truist Financial lifted their target price on shares of American Healthcare REIT from $27.00 to $29.00 and gave the company a “buy” rating in a report on Friday, November 15th. Colliers Securities raised shares of American Healthcare REIT from a “hold” rating to a “moderate buy” rating in a report on Sunday, October 13th. Finally, JMP Securities lifted their price objective on shares of American Healthcare REIT from $18.00 to $30.00 and gave the company a “market outperform” rating in a report on Friday, September 20th. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, American Healthcare REIT has an average rating of “Moderate Buy” and a consensus price target of $25.13.

American Healthcare REIT Price Performance

Shares of NYSE AHR opened at $28.55 on Friday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.37 and a current ratio of 0.37. The firm has a fifty day moving average of $26.54 and a 200 day moving average of $20.92. The firm has a market cap of $4.37 billion and a PE ratio of -59.48. American Healthcare REIT, Inc. has a one year low of $12.63 and a one year high of $29.99.

American Healthcare REIT (NYSE:AHR) last released its earnings results on Tuesday, November 12th. The company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.35). The company had revenue of $523.81 million for the quarter, compared to analysts’ expectations of $474.26 million. American Healthcare REIT had a negative return on equity of 1.87% and a negative net margin of 1.84%. American Healthcare REIT’s quarterly revenue was up 12.8% compared to the same quarter last year. As a group, research analysts predict that American Healthcare REIT, Inc. will post 1.42 EPS for the current fiscal year.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.